TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells (Q46340978)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 September 2008

Language	Label	Description	Also known as
English	TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells	scientific article published on 13 September 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

TLR-4 agonistic lipopolysaccharide upregulates interleukin-8 at the transcriptional and post-translational level in vascular smooth muscle cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

toll-like receptor

0 references

lipopolysaccharide

1 reference

based on heuristic

inferred from title

author name string

Taek-Jong Hong

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Ji-Eun Ban

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Kyung-Ha Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Yong-Hae Son

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Sun-Mi Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Seong-Kug Eo

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Hee-Ju Park

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Byung-Yong Rhim

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Koanhoi Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

publication date

13 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

50

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

1-2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

34-39

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Transformation of mammalian cells by constitutively active MAP kinase kinase

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

A novel neutrophil-activating factor produced by human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Inhibition of homodimerization of Toll-like receptor 4 by curcumin

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2008.08.006

7 January 2021

Identifiers

10.1016/J.VPH.2008.08.006

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18824136

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46340978&oldid=2106386183"